Clinical Trials in Colorado

Showing 2501-2520 of 8,657 trials

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

NCT04880863

Phase 2a Open-Label, Multicenter Trial of Naptumomab Estafenatox (NAP), following Obinutuzumab Pretreatment, on Days -13 and -12. NAP will be administered on Days 1-4 of treatment cycles 1-6, followed by docetaxel on Day 5. Starting cycle 7, NAP at a higher dose will be administered on Day 1 only and docetaxel on Day 2, in 21 days treatment cycles. When NAP is administered as monotherapy and not earlier than cycle 7, NAP will be administered on Day 1 only and cycles will be of 28 days treatment cycle.

Non-small Cell Lung Cancer

NeoTX Therapeutics Ltd.38 participantsStarted Oct 2021

Daphne, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +8 more locations

COMPLETEDPhase 250 miles

LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris

NCT01536886

The purpose of this study is to investigate whether LEO 90100 and calcipotriol plus betamethasone are effective in the treatment of psoriasis vulgaris.

Psoriasis Vulgaris

LEO Pharma376 participantsStarted May 2012

Hot Springs, Arkansas, United States • Los Angeles, California, United States • Oceanside, California, United States +36 more locations

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris

Find Trials by Condition in Colorado

Virta Intervention in CommuniTies in cOloRado (VICTOR-Pilot)

The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B

Novel Approaches for Quantitative Assessment of Adherence

MitoQ Supplementation and Cardiovascular Function in Healthy Men and Women

A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

Study of LP-184 in Patients With Advanced Solid Tumors

MGD019 DART® Protein in Unresectable/Metastatic Cancer

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer

ViBone in Cervical and Lumbar Spine Fusion

Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions